This episode delves into the intricate design of Phase 1 safety trials, emphasizing the paramount importance of volunteer safety. We explore dosing regimens, ethical considerations, and the specific procedures used to ensure the well-being of participants. The discussion covers the structure of trial protocols, including informed consent procedures, and adaptive safety measures that allow for adjustments during the trial based on emerging safety data. The role of regulatory bodies like the International Council for Harmonisation (ICH) and Institutional Review Boards (IRBs) is also examined, highlighting their crucial role in overseeing the ethical and scientific conduct of these trials. The episode aims to provide a comprehensive overview of the framework that governs Phase 1 trials, emphasizing the balance between scientific progress and partici ...